Found: 13
Select item for more details and to access through your institution.
Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 7, p. 1539, doi. 10.1007/s12094-024-03383-x
- By:
- Publication type:
- Article
Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 1, p. 163, doi. 10.1007/s10549-023-07094-9
- By:
- Publication type:
- Article
Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4452, doi. 10.3390/cancers15184452
- By:
- Publication type:
- Article
Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1 , CLNS1A, and ILF2 in Luminal Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4118, doi. 10.3390/cancers13164118
- By:
- Publication type:
- Article
New Forms of Administration of Herceptin®.
- Published in:
- Cancer & Chemotherapy Reviews, 2015, v. 10, n. 2, p. 53
- By:
- Publication type:
- Article
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID‐19 Pandemic in Spain.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. e1339, doi. 10.1634/theoncologist.2020-0363
- By:
- Publication type:
- Article
Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 111, doi. 10.1634/theoncologist.2014-0379
- By:
- Publication type:
- Article
Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 8, p. 917, doi. 10.1634/theoncologist.2012-0479
- By:
- Publication type:
- Article
Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 1, doi. 10.1634/theoncologist.2008-0137
- By:
- Publication type:
- Article
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11419, doi. 10.3390/ijms241411419
- By:
- Publication type:
- Article
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.605633
- By:
- Publication type:
- Article
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01649-w
- By:
- Publication type:
- Article